Refine by
Vaccination Suppliers Serving Libya
234 companies found
based inPhoenix, ARIZONA (USA)
We are building a successful company based on powerful breakthrough science. We believe our efforts hold the potential to end cancer. We are determined to offer humanity a better life, free from cancer. While our goal is hugely ambitious, we are ...
based inKumamoto, JAPAN
At KM Biologics, we are driven by our mission of making the world a healthier place through the unlimited possibilities of biotechnology. Through our three main areas of business, KM Biologics supplies first-rate biological products and services ...
An inactivated quadrivalent split (HA) seasonal influenza vaccine produced using embryonated chicken eggs. The vaccine contains 15 μg or more of HA proteins for each strain per adult dose. The strains used to make the vaccine are decided by the ...
based inSan Diego, CALIFORNIA (USA)
Resilience is your biomanufacturing innovation partner, leading the pursuit of novel medicines by revolutionizing how they’re made, funded and scaled. The technology of manufacturing complex medicines, like cell and gene therapies, hasn’t kept pace ...
Now more than ever, global vaccine innovators need a biomanufacturing partner with the ability to adapt skillfully and the capacity to scale rapidly. Enter ...
based inLangenfeld, GERMANY
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ...
ARTES offers a range of vaccine producing cell lines and processes for out-licensing and technology transfer. All listed cell lines are based on our safe and high yield yeast expression system Hansenula ...
based inPhiladelphia, PENNSYLVANIA (USA)
Chimeron Bio is building a portfolio of self-amplifying RNA therapeutics and vaccines to bring more effective gene therapies and personalized medicines to patients. We are developing a compelling portfolio of innovative and personalized saRNA-based ...
Self-amplifying RNA (saRNA) replicon is a type of RNA genome that is unique to certain families of viruses. This highly specialized system lets the virus make multiple copies of its RNA genome, and therefore encoded proteins, from just a single RNA ...
based inLaramie, WYOMING (USA)
GlycoBac has developed a sensitive assay for infectious Sf-rhabdovirus particles using our proprietary Sf-RVN cell line. GlycoBac has partnered with MilliporeSigma to facilitate the distribution of our Sf-RVN cell line for commercial vaccine and ...
based inMadison, WISCONSIN (USA)
Scarab Genomics LLC was founded in 2002 by Professor F. Blattner, a serial entrepreneur and founder of DNASTAR Inc. and Nimblegen Inc. and a world-renowned scientist and leader in the genomics revolution. The Company was established to commercialize ...
Cross-Reactive Material 197 (CRM197) is a non-toxic mutant form of the 58-kd diphtheria toxin that serves as a carrier protein for polysaccharides and haptens in a number of conjugate vaccines, to enhance their immunogenicity. The effectiveness of ...
based inKnowsley, UNITED KINGDOM
NeedleSmart is market leading, patented needle destruction technology engineered in the UK. The NeedleSmart Pro device takes a hypodermic needle at the point of use, heats it to over 1,300 degrees Celsius and compresses it into a ball. It takes just ...
based inWest Sussex, UNITED KINGDOM
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than ...
We are proud to offer a wide range of pioneering aluminium-free allergy vaccines and diagnostics. Our short course of treatments are efficient, effective and convenient. As a healthcare professional, you understand the importance of convenience in ...
based inO Porriño, Pontevedra, SPAIN
In CZ Vaccines we develop and manufacture an extensive range of vaccines and biological products for multinational companies, laboratories and governments around the world. CZ Vaccines belongs to Zendal, a biopharmaceutical group that draws together ...
based inUlm, GERMANY
Digital health offers, networked testing and vaccination infrastructure solutions. We are there with the vaccination bus and offer the opportunity to have Sars-CoV-2 antibodies determined. The result is delivered digitally as usual, if desired ...
The Smart Health Check App contains all functions that are necessary for a digital test strategy and a sustainable opening concept. You can safely save test results as well as vaccination and recovery certificates and have them shown and checked if ...
based inOxford, UNITED KINGDOM
Utilising unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide. SpyBiotech came into being to change that. Our pioneering technology, the proprietary protein superglue SpyTag/SpyCatcher, enables us ...
CMV is the most common virus that most people have never heard of, even though it has now been identified as a high priority for vaccines development by key authorities such as the FDA and Institute of ...
based inBuffalo, NEW YORK (USA)
POP Biotechnologies, Inc. (POP BIO) is dedicated to addressing critical medical challenges with advanced nanotechnologies. POP BIO’s key breakthrough, the porphyrin-phospholipid (PoP) platform, facilitates the creation of powerful light-targeted ...
The SNAP (Spontaneous Nanoliposome Antigen Particleization) platform technology is a unique liposome-based system that functions as a potent vaccine adjuvant designed to address functional and practical limitations facing vaccine ...
based inSaint-Herblain, FRANCE
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines ...
IXIARO® is a vaccine indicated for the prevention of disease caused by JE virus, approved for use in individuals 2 months of age and older. Severe allergic reaction after a previous dose of IXIARO®, any other JEV vaccine, or any component of ...
based inAix-en-Provence, FRANCE
PI France is a company that provides solutions for precision motion and positioning, specializing in technologies such as piezo elements. The company’s expertise is applied in various fields, including the production of smart vaccine patches, ...
based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
A particularly innovative immunotherapy, TG4050 is the lead myvac® candidate. This individualized treatment is based on the specific mutations that are identified in each patient’s ...
based inSan Carlos, CALIFORNIA (USA)
Vaxcyte is a clinical-stage vaccine innovation company based in San Carlos, California with a unique ability to rapidly engineer, optimize and manufacture superior, high-fidelity vaccines at scale. We do this by re-engineering how highly complex ...
based inBogotá, COLORADO (USA)
At Integra IT, we’re on a mission to expand clinical research possibilities worldwide, especially in diversity, inclusion, and emerging countries. Our comprehensive software ecosystem is cost-convenient and high-efficient for all clinical research ...
The Vaccination Record Tracker (VRT) is a web-based platform for recording and monitoring vaccine distribution for a whole country with a scheme card for each citizen. Customize vaccine schemes according to the national or regional health care ...
based inSan Diego, CALIFORNIA (USA)
Ichor Medical Systems Inc., a privately-held biotech company founded in San Diego in 1994, is developing products based on the in vivo application of electroporation to enhance intracellular delivery of nucleic acid-based drugs encoding therapeutic ...
based inAalborg Øst, DENMARK
2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP platform. To develop novel, cost ...
2A Pharma’s AAVLP-HER2/Neu peptide vaccine candidate has in laboratory tests been shown to induce antibodies specific to human HER2. In mouse models, regression of breast cancer tumors was observed after vaccination. In a proof-of-principle ...